PHS
MXL icon

PFM Health Sciences’s MaxLinear MXL Stock Holding History

PFM Health Sciences’s Portfolio MXL Stock Details MXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-81,443
Closed -$1.2M – 89
2015
Q4 		$1.2M Buy
81,443
+45
+0.1% +$677 0.04% 67
2015
Q3 		$1.01M Sell
81,398
-111,336
-58% -$1.23M 0.03% 67
2015
Q2 		$2.33M Buy
+192,734
New +$1.94M 0.06% 79

Other funds holding MXL

ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PFM Health Sciences's MXL Position: Q1 2016 in Review

PFM Health Sciences sold out of MaxLinear (MXL) in Q1 2016, closing a stake of 81,443 shares — an estimated $1.2M sold.

PFM Health Sciences first reported a position in MXL in Q2 2015 and held it in 3 quarters. The position peaked at $2.33M in Q2 2015. 189 funds tracked by Wall St. Rank hold MXL as of Q1 2016.

  • PFM Health Sciences reported no remaining MaxLinear position as of Q1 2016 after selling out during the quarter.
  • PFM Health Sciences sold 81,443 MaxLinear shares in Q1 2016, an estimated $1.2M.
  • PFM Health Sciences first reported a position in MaxLinear in Q2 2015 and held it in 3 quarters.
  • PFM Health Sciences's MaxLinear position peaked at $2.33M in Q2 2015.
  • 189 funds tracked by Wall St. Rank held MaxLinear as of Q1 2016.

Based on PFM Health Sciences's 13F filing for Q1 2016, filed 16 May 2016.